Resistance to neoadjuvant talazoparib in triple-negative breast cancer by BRN2-induced ATR/STAT3 pathways or SHLD2 subclone expansion

Journal:
Proceedings of the National Academy of Sciences of the United States of America
Published:
DOI:
10.1073/pnas.2513742123
Affiliations:
4
Authors:
15
Go to article
Institutions Authors Share
The University of Texas MD Anderson Cancer Center, United States of America (USA)
13.500000
13.500000
 0.90
The University of Texas Health Science Center at Houston (UTHealth), United States of America (USA)
1.500000
 0.10
Interested in Oncology and Carcinogenesis?